Study on Kidney Toxicities of WK-38 for Treatment Vascular Diseases in Rats

혈관질환 억제 효능이 있는 WK-38의 백서 신장 독성연구

  • Kim, Eun-Ju (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Lee, An-Sook (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Shin, Sun (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Kim, Sung-Yeon (Dept. of Pharmacy, College of Pharmacy, Wonkwang University) ;
  • Chang, Bo-Yoon (Dept. of Pharmacy, College of Pharmacy, Wonkwang University) ;
  • Lee, Ho-Sub (Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Kang, Dae-Gill (Professional Graduate School of Oriental Medicine, Wonkwang University)
  • 김은주 (원광대학교 한의학전문대학원 한약자원개발학과) ;
  • 이안숙 (원광대학교 한의학전문대학원 한약자원개발학과) ;
  • 신선 (원광대학교 한의학전문대학원 한약자원개발학과) ;
  • 김성연 (원광대학교 약학대학 약학과) ;
  • 장보윤 (원광대학교 약학대학 약학과) ;
  • 이호섭 (원광대학교 한의학전문대학원 한약자원개발학과) ;
  • 강대길 (원광대학교 한의학전문대학원 한약자원개발학과)
  • Published : 2009.12.30

Abstract

The kidney toxicities of WK-38 used for improvement of the vascular diseases, was examined using male and female Sprague-Dawley rats. The male and female rats were divided into 4 groups for intragastrical treatment with doses of 0, 5, 50, and 500 mg/kg/day for 13 weeks, respectively. In all male and female rats treated with WK-38, no mortality and gross pathological findings were shown for 13 weeks. There was substantially no change in body weight in all rats with treatment of WK-38. Urine osmolality as renal functional parameters were not exchanged in all rats treated with WK-38. The renal functional parameters including electrolytes excretory rate, creatinine clearance, and solute-free water reabsorption were significantly augmented on account of increase in urinary volume in female rats treated with WK-38, but not male. In summary, this study demonstrates that WK-38 exhibits no toxicity on kidney in all male and female rats.

Keywords

References

  1. 이정윤, 홍성찬, 김자영. 심혈관계질환(CVD) 위험인자 와 혈중 C-reactiveprotein(CRP)농 도에 미치는 유산소훈련의 효과. 운동영양학회지. 2003;3:297-302
  2. Fuster, V., Gotto, A.M. Jr. Risk reduction. Circulation. 2000;102(4):94-102.
  3. 약물학분과회. 약물학. 서울:신일상사. 2002: 426-86.
  4. 안병민, 이동수, 백종태, 장성희, 장이선. 식물제 제에 의한 간손상 빈도. 식품의약품안전청연구 보고서. 2002;6:1045-6.
  5. Nortier, J.L., Vanherweghem, J.L. Renal interstital fibrosis and urothelial carcinoma associated with the use ofa Chinese herd(Aristolochia fangchi). Toxicology. 2002;181-182:577-80 https://doi.org/10.1016/S0300-483X(02)00486-9
  6. Depierreux, M., Van, D.B., Vanden, H.K., Vanherweghem, J.L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs, Am. J. Kidney Dis. 1994;24(2):172-80. https://doi.org/10.1016/S0272-6386(12)80178-8
  7. Vanherweghem, J.L., Depierreux, M., Tielemans, C., Abramowicz, D., Dratwa, M., Jadoul, M., Richard, C., Vandervelde, D., Verbeelen, D., Vanhaelen-Fastre, R. Rapidly progressive intersitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341(8842):387-91. https://doi.org/10.1016/0140-6736(93)92984-2
  8. 육창수. 원색 한국약용식물도감. 아카데미서적. 1993:158.
  9. 육창수. 한약학 II. 동명사. 1992:206
  10. 허준. 국역증보동의보감. 남산당. 1981:1204.
  11. 한대석. 본초학. 동명사. 1962:83.
  12. 전국 한의학대학 본초학 교수 본초학. 영림사. 1991:291-2.
  13. 지형준, 이상인. 대한약전 외 한약생약규격집. 한국메디칼인덱스사. 1998:648-9.
  14. 서수남, 우병점. 신농본초경. 河北:河北科學技 術出版社. 1994:90.
  15. 高木敬次郞, 木村正康, 原田正敏. 和漢藥物學. 南山堂. 1982:248
  16. Watanabe, K., Watanabe, H., Goto, Y., Yamaguchi, M., Yamamoto, N., Hagino, K. Pharmacological Properties of Magnolol and Honokiol Extracted from Magnolia officinalis: Central Depressant Effects. Planta Med. 1983;49(10):103-8. https://doi.org/10.1055/s-2007-969825
  17. 배기환. 한국의 약용식물. 서울:교학사.2000: 170.
  18. Fukuhara, Y., Yoshida, D.Paenil: A bioantimutagen isplated from a crude drug, Moutan Cortex. Agric Biol Chem. 1987;51 :1441-6. https://doi.org/10.1271/bbb1961.51.1441
  19. Ryuichiro, L., Yoshikawa, H., Komura, H., Kada, T. Specificities of bio-antimutagens in plant kingdaom. Agric Biol Chem. 1984;48: 2587-91 https://doi.org/10.1271/bbb1961.48.2587
  20. Mitsuo, M., Maruyara, H., Kameoka, H. Essential oil constituents of "Moutan Radics Cortex" Paeonia moutan Sims.(=P.suffruticosa Andrews). Agric Biol Chem. 1983;47:2925-7. https://doi.org/10.1271/bbb1961.47.2925
  21. 한대석. 생약학. 서울:동명사. 2001:116-8
  22. Te, J., Duan, H., Yang, X., Yan, W., Zheng, X. Anti-thro mbosis model in vivo. Planta Med. 2001;67:766-7. https://doi.org/10.1055/s-2001-18364
  23. Tsuboi, H., Hossain, K., Akhand, A.A., Takeda K., Du, J., Rifa'i, M., DaiY., Hayakawa, A., Suzuki, H., Nakashima, I.Paeoniflorin induces apoptosis of lymphocytes through a redox-linked mechansim, J. Cell Biochem. 2004;93(1):162-72 https://doi.org/10.1002/jcb.20134
  24. Yang, H. O., Ko, W.K., Kim, J.Y., Ro,H.S. Paeoniflorin:an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia. 2004;75(1):45-9. https://doi.org/10.1016/j.fitote.2003.08.016